The overall goal of the USC Alzheimer’s Disease Research Center (ADRC) Research and Education Component (REC) is to support educational activities that complement and/or enhance the training of a workforce to meet the nation’s biomedical, behavioral, and clinical research needs in Alzheimer’s disease and related dementia (ADRD) research, as well as to diversify the workforce.
The seminar series hosts various topics regarding basic science research, clinical research, and career development. With both internal and external speakers, we hope this series will introduce you to exciting Alzheimer’s disease and related dementias (AD/ADRD) research while providing the opportunity to network and collaborate with the ADRC.
Talks are held via Zoom on Fridays from 1–2 PM PST. Please use this Zoom link to attend the seminars: usc.zoom.us/j/96549031381
Meeting ID: 965 4903 1381 Passcode: 661977
-
Identifying potential new AD therapeutics by investigating the efficacy of already approved drugs in a lab model and through Medicare claims
Rachel Litke, MD, PhD
Post-Doctoral Fellow, Icahn School of Medicine at Mount Sinai
-
The role of bilingualism and cognition cross-nationally
Miguel Arce Rentería, PhD
Assistant Professor of Neuropsychology, Columbia University
-
Delirium and Dementia in the Geriatric Emergency Department
Rachel Skains, MD, MSPH
Assistant Professor at Birmingham, School of Medicine, The University of Alabama
-
Functional genomics to understand APOE common variants and mRNA transcripts in Alzheimer’s disease
Liang Ma, Ph. D.
Assistant Professor at Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, University of Texas Health Science Center San Antonio
-
Career development in Alzheimer’s Research
Hussein Yassine, MD
Professor of Neurology, Keck School of Medicine of USC
-
Targeting brain insulin signaling in Alzheimer’s: A focus on the BBB
Elizabeth Rhea, PhD
Research Assistant Professor University of Washington, Division of Gerontology and Geriatric Medicine
Elizabeth Rhea is an investigator in the Division of Gerontology at the University of Washington and VA Puget Sound in Seattle Washington after receiving her PhD from Vanderbilt University in 2014. Her basic science lab is focused on studying the role of brain insulin signaling in dementia. While insulin signaling in the periphery is well-characterized, […]
-
The intersection of FDG-PET and dementia associated biology in clinical decision making
David Jones, MD
Behavioral Neurologist, Director of the Neurology Artificial Intelligence Program (NAIP), Mayo Clinic
Dr. David T. Jones is a behavioral neurologist and Director of the Neurology Artificial Intelligence Program (NAIP) at Mayo Clinic. He is internationally recognized for his work at the intersection of clinical neurology, quantitative neuroimaging, and artificial intelligence. Dr. Jones specializes in cognitive and behavioral neurology, with a focus on early-onset and atypical Alzheimer's disease, […]
-
Structural biology of receptors controlling innate immunity in Alzheimer’s disease
Tobias S. Ulmer, PhD
Associate Professor of Physiology and Neuroscience at USC
Neurodegenerative diseases are generally driven by the misfolding of a single protein, a-synuclein in Parkinson's disease, and Aß(1-42) in Alzheimer's disease. While it is crucial to understand these misfolding processes, it has also become clear that additional proteins play decisive roles in disease pathogenesis.
-
What Can We Learn from High-Frequency Digital Assessments?
Jason Hassenstab, PhD
Associate Protessor of Neurology and of Psychological and Brain Sciences, WashU
Jason Hassenstab, PhD is the Norman J. Stupp Protessor of Neurology and Professor of Psychological & Brain Sciences at Washington University in St. Louis. His laboratory, the Cognitive Technology Research Lab (CTRLab) develops novel assessment approaches for cognition in normal aging and neurodegenerative diseases. He is the Principal Investigator of the ARC-Down syndrome network (ARC-DS), […]
-
Writing Grant Applications for Observational Studies
John Ringman, MD
Clinical Professor of Neurology at the Memory and Aging Center, eck School of Medicine of USC.
-
Pericyte-based therapy to treat Alzheimer’s disease
Ruslan Rust
Assistant Professor of Research in Physiology and Neuroscience at the Zilkha Neurogenetic Institute, Keck School of Medicine of USC
-
Diabetes, related strategies and AD/ADRD
Jose A Luchsinger, MD, MPH
Professor of Medicine and Professor of Epidemiology, Columbia University Irving Medical Center